238 related articles for article (PubMed ID: 32716768)
1. The Regulation of COVID-19 "Challenge" Studies.
Menikoff J
Am J Bioeth; 2020 Jul; 20(7):80-82. PubMed ID: 32716768
[No Abstract] [Full Text] [Related]
2. Covid-19 and the race for a vaccine.
Cueto M
Hist Cienc Saude Manguinhos; 2020; 27(3):715-717. PubMed ID: 33111785
[No Abstract] [Full Text] [Related]
3. Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
McPartlin SO; Morrison J; Rohrig A; Weijer C
BMJ; 2020 Nov; 371():m4258. PubMed ID: 33168564
[No Abstract] [Full Text] [Related]
4. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
Heininger U
Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
[No Abstract] [Full Text] [Related]
5. Keeping track of the SARS-CoV-2 vaccine pipeline.
Parker EPK; Shrotri M; Kampmann B
Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
[TBL] [Abstract][Full Text] [Related]
6. The Race to Develop a COVID-19 Vaccine.
Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132
[TBL] [Abstract][Full Text] [Related]
7. Progress and Concept for COVID-19 Vaccine Development.
Wu SC
Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
[No Abstract] [Full Text] [Related]
8. COVID-19 disrupts vaccine delivery.
Nelson R
Lancet Infect Dis; 2020 May; 20(5):546. PubMed ID: 32311326
[No Abstract] [Full Text] [Related]
9. All roads lead to coronavirus.
Abbasi K
J R Soc Med; 2020 Mar; 113(3):91. PubMed ID: 32160122
[No Abstract] [Full Text] [Related]
10. All eyes on a hurdle race for a SARS-CoV-2 vaccine.
Gaebler C; Nussenzweig MC
Nature; 2020 Oct; 586(7830):501-502. PubMed ID: 33077943
[No Abstract] [Full Text] [Related]
11. Next-generation vaccine platforms for COVID-19.
van Riel D; de Wit E
Nat Mater; 2020 Aug; 19(8):810-812. PubMed ID: 32704139
[No Abstract] [Full Text] [Related]
12. Are Genetic Vaccines the Right Weapon against COVID-19?
Conforti A; Marra E; Roscilli G; Palombo F; Ciliberto G; Aurisicchio L
Mol Ther; 2020 Jul; 28(7):1555-1556. PubMed ID: 32553431
[No Abstract] [Full Text] [Related]
13. Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.
Wang EA; Zenilman J; Brinkley-Rubinstein L
JAMA; 2020 Sep; 324(11):1031-1032. PubMed ID: 32808972
[No Abstract] [Full Text] [Related]
14. [Not Available].
Nau JY
Rev Med Suisse; 2020 Jun; 16(696):1176-1177. PubMed ID: 32496711
[No Abstract] [Full Text] [Related]
15. Developing Covid-19 Vaccines at Pandemic Speed.
Lurie N; Saville M; Hatchett R; Halton J
N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
[No Abstract] [Full Text] [Related]
16. COVID-19 therapies and vaccine landscape.
Nat Mater; 2020 Aug; 19(8):809. PubMed ID: 32704138
[No Abstract] [Full Text] [Related]
17. COVID-19: Act First, Think Later.
Stoeklé HC; Hervé C
Am J Bioeth; 2020 Jul; 20(7):W1. PubMed ID: 32400288
[No Abstract] [Full Text] [Related]
18. Preparing for the vaccine.
Nat Biotechnol; 2020 Nov; 38(11):1219. PubMed ID: 33110209
[TBL] [Abstract][Full Text] [Related]
19. COVID-19: The Need for Immunoprevention at Industrial Scale.
Halstead SB
Am J Trop Med Hyg; 2020 Jun; 102(6):1151. PubMed ID: 32274985
[No Abstract] [Full Text] [Related]
20. Resource Allocation in COVID-19 Research: Which Trials? Which Patients?
Wieten S; Burgart A; Cho M
Am J Bioeth; 2020 Jul; 20(7):86-88. PubMed ID: 32716767
[No Abstract] [Full Text] [Related]
[Next] [New Search]
